Atlas Trials

Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Subjects With A Genetic Cholesterol Disorder.

Clinical trial NCT00145431 · TERMINATED

Trial details

NCT number
NCT00145431
Sponsor
Pfizer
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Hyperlipoproteinemia Type III
Start date
2005-03-01
Primary completion
2006-12-01
Enrollment
41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.